# Comparison of Different Vascular Closure Device in TAVI

Study · id `cardio:ct-nct05491070` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05491070](<https://clinicaltrials.gov/study/NCT05491070>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05491070

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 260 participants.

## Technical summary

Registry record NCT05491070. Randomized; no masking; primary purpose treatment. Start 2018-03-20 (actual); primary completion 2023-04-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 260 participants (enrolled count; ClinicalTrials.gov record NCT05491070, source copy `cardio:ctgov-nct05491070-2024-09-23`, retrieved 2026-10-26)
- Started: 2018-03-20 (actual) (ClinicalTrials.gov record NCT05491070, source copy `cardio:ctgov-nct05491070-2024-09-23`, retrieved 2026-10-26)
- Primary completion: 2023-04-13 (actual) (ClinicalTrials.gov record NCT05491070, source copy `cardio:ctgov-nct05491070-2024-09-23`, retrieved 2026-10-26)
- Completion: 2024-04-30 (actual) (ClinicalTrials.gov record NCT05491070, source copy `cardio:ctgov-nct05491070-2024-09-23`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT05491070, source copy `cardio:ctgov-nct05491070-2024-09-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05491070-2024-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Different Vascular Closure Device in TAVI
- Condition: Aortic Valve Stenosis
- Condition: Transcatheter Aortic Valve Implantation
- Intervention (Device): Vascular closure device (Angio-Seal, Progilde)
- Lead sponsor: National Taiwan University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Dual ProGlide vs ProGlide and Angio-Seal for Femoral Access Hemostasis After Transcatheter Aortic Valve Replacement: A Randomised Comparative Trial (`cardio:pubmed-39245341`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d8403d62af6d15786cc31d6d03fb49a27b91a253f21a3ff2dbaf345e57c31744
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
